This analysis directly determines the content and strength of the Notice Letter
An Evidence-Based Perspective (drlewis.com, Jan 4, 2026) DrLewis.com GLP-1 Medications & Mental Health: Facts vs Myths (drlewis.com, Nov 26, 2025) Axios Health News COVID-era telehealth prescribing extended again (www.axios.com, Nov 18, 2024) Axios Trump announces Medicare coverage of weight-loss drugs (www.axios.com, Nov 6, 2025) Associated Press Biden proposes Medicare and Medicaid cover costly weight-loss drugs (apnews.com, Nov 26, 2024) TheraThink Insurance Reimbursement Rates for Psychiatrists [2026] (therathink.com, 2026) Blue Cross Blue Shield of Texas Provider Notice on GLP-1 Supply Limit (www.bcbstx.com, Oct 4, 2024) All sources verified current as of publication date (February 2026)
If you're unsure youve found your medication sweet spot & you'd like to understand your ADHD brain better check out the FREE 10-minute ADHD Check-up and Reset workshop
Semaglutide's Role in Reducing Sleep Apnea Symptoms Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone controlling hunger and blood sugar